University of Chicago
Chicago, IL
- Oncology Fellowship
2018
Duke Medical Center
Durham, MD
- Internal Medicine - Residency
2015
University of Pennsylvania
Philadelphia
MD
2012
A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer.
A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer. Clin Lung Cancer. 2023 Feb 08.
PMID: 36841727
Response to Provenzano et?al. and De Carlo et?al.
Response to Provenzano et?al. and De Carlo et?al. J Thorac Oncol. 2023 Feb; 18(2):e13-e14.
PMID: 36682841
Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression.
Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression. Clin Lung Cancer. 2023 Jan 25.
PMID: 36806414
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2023 01; 7:e2200273.
PMID: 36603171
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma.
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdac183.
PMID: 36814898
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade.
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade. Nat Cancer. 2022 12; 3(12):1498-1512.
PMID: 36443406
Immunotherapy partners after progression: Right place, right time?
Immunotherapy partners after progression: Right place, right time? Cancer. 2023 01 15; 129(2):181-183.
PMID: 36420775
Meeting an un-MET need: Targeting MET in non-small cell lung cancer.
Meeting an un-MET need: Targeting MET in non-small cell lung cancer. Front Oncol. 2022; 12:1004198.
PMID: 36338701
Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy.
Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy. J Thorac Oncol. 2022 09; 17(9):1130-1136.
PMID: 35788405
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy.
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy. Int J Radiat Oncol Biol Phys. 2022 11 15; 114(4):645-654.
PMID: 35753553